Skip Navigation

European Heart Journal 2000 21(22):1815-1816; doi:10.1053/euhj.2000.2334
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Oxenham, H.
Right arrow Articles by Sharpe, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oxenham, H.
Right arrow Articles by Sharpe, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Prognostic stratification in heart failure: what's the point?

H. Oxenham and N. Sharpe

Department of Medicine, Auckland Hospital, Auckland, New Zealand

References

  1. Cowburn P, Cleland J, Coats A, Komajda M. Risk stratification in chronic heart failure. Eur Heart J. 1998;19:696–710[Free Full Text]
  2. Wright D, Tan L. The role of exercise testing in the evaluation and management of heart failure. Postgrad Med J. 1999;75:453–458[Abstract/Free Full Text]
  3. Stelken A, Younis L, Jennison S. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischaemic and dilated cardiomyopathy. J Am Coll Cardiol. 1996;27:345–352[Abstract]
  4. Gianuzzi P, Temporelli P, Bosimini E. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol. 1996;28:383–390[Abstract]
  5. Xie G, Berk M, Smith M, Gurley J, DeMaria A. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol. 1994;24:132–139[Abstract]
  6. Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and haemodynamic correlations and prognostic implications. J Am Coll Cardiol. 1993;22:808–815[Abstract]
  7. Pozzoli M, Traversi E, Coiffi G, Stenner R, Sanarico M, Tavazzi L. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation. 1997;95:1222–1230[Abstract/Free Full Text]
  8. Temporelli P, Corra U, Imparato A, Bosimini E, Scapellato F, Gianuzzi P. Reversible restrictive left ventricular diastolic filling with optimised oral therapy predicts a more favourable prognosis in patients with chronic heart failure. J Am Coll Cardiol. 1998;31:1591–1597[Abstract/Free Full Text]
  9. Tabet J, Logeart D, Geyer C. Comparison of the prognostic value of left ventricular filling and peak oxygen uptake in patients with systolic heart failure. Eur Heart J. 2000;21:1864–1871[Abstract/Free Full Text]
  10. Yu C, Sanderson J, Shum I. Diastolic dysfunction an natriuretic peptides in systolic heart failure: Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J. 1996;17:1694–1702[Abstract/Free Full Text]
  11. Struthers A. Further defining the role for natriuretic peptide levels in clinical practice. Eur Heart J. 1999;20:712–714[ISI][Medline]
  12. Fruhwald F, Fahrleitner A, Watzinger N. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy. Eur Heart J. 1999;20:1415–1423[Abstract/Free Full Text]
  13. Troughton R, Frampton C, Yandle T, Espiner E, Nicholls M, Richards A. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000;335:1126–1130
  14. Murdoch D, McDonagh T, Byrne J. Titration of vasodilaor therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the haemodynamic and neuroendocrine effects of tailored versus empirical treatment. Am Heart J. 1999;138:1126–1132[CrossRef][ISI][Medline]
  15. Richards A, Doughty R, Nicholls M. Neurohumoral prediction of benefit from carvedilol in ischaemic left ventricular dysfunction. Circulation. 1999;99:786–792[Abstract/Free Full Text]
  16. Lim P, MacFadyen R, Struthers A. Is there a role for renin profiling in selecting chronic heart failure patients for ACE inhibitor treatment? Heart. 2000;83:257–261[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Oxenham, H.
Right arrow Articles by Sharpe, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oxenham, H.
Right arrow Articles by Sharpe, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?